Half Yearly Results Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Mar'26
Sep'25
Mar'25
Sep'24
Mar'24
Sep'23
Sep'22
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Mar 2026 is 0.00% vs 0.00% in Sep 2025
Standalone Net Profit
Growth in half year ended Mar 2026 is 30.00% vs -66.67% in Sep 2025
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Mar 2026 is 30.00% vs -66.67% in Sep 2025
Interest
No Interest in the last few periods
Operating Profit Margin (Excl OI)
Growth in half year ended Mar 2026 has improved from Sep 2025
Compare Half Yearly Results Of Tulasee Bio-Eth. With
Figures in Cr
Standalone Half Yearly Results
Change(INR)
Change(%)
Net Sales
0.00
6.05
-6.05
-100.00%
Other Operating Income
0.00
0.00
0.00
Total Operating income
0.00
6.05
-6.05
-100.00%
Raw Material Cost
0.00
0.00
0.00
Purchase of Finished goods
0.00
5.37
-5.37
-100.00%
(Increase) / Decrease In Stocks
0.00
0.00
0.00
Employee Cost
0.00
0.07
-0.07
-100.00%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
0.07
0.12
-0.05
-41.67%
Total Expenditure (Excl Depreciation)
0.07
5.56
-5.49
-98.74%
Operating Profit (PBDIT) excl Other Income
-0.07
0.49
-0.56
-114.29%
Other Income
0.00
0.15
-0.15
-100.00%
Operating Profit (PBDIT)
-0.07
0.64
-0.71
-110.94%
Interest
0.00
0.00
0.00
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
-0.07
0.64
-0.71
-110.94%
Depreciation
0.00
0.00
0.00
Profit Before Tax
-0.07
0.63
-0.70
-111.11%
Tax
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
-0.07
0.63
-0.70
-111.11%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
-0.07
0.63
-0.70
-111.11%
Equity Capital
5.84
6.27
-0.43
-6.86%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
-0.12
1.00
-1.12
-112.00%
Diluted Earnings per share
-0.13
1.00
-1.13
-113.00%
Operating Profit Margin (Excl OI)
0.00%
8.10%
0.00
-8.10%
Gross Profit Margin
0.00%
10.58%
0.00
-10.58%
PAT Margin
0.00%
10.41%
0.00
-10.41%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
No Net Sales in the last few periods
Half Yearly - Standalone Net Profit
Standalone Net Profit -0.07 Cr
in Mar 2026Figures in Cr
Growth in half year ended Mar 2026 is 30.00% vs -66.67% in Sep 2025
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -0.07 Cr
in Mar 2026Figures in Cr
Growth in half year ended Mar 2026 is 30.00% vs -66.67% in Sep 2025
Half Yearly - Interest
No Interest in the last few periods
Half Yearly - Operating Profit Margin (Excl OI)
No Operating Profit Margin (Excl OI) in the last few periods
Footer loading
